Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: A systematic review and meta-analysis
In this medfyle
Patients with type 1 diabetes should be considered at risk for NAFLD.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Expert commentary
About this Medfyle
This summary is based upon an article appearing in the journal entitled The Journal of Clinical Endocrinology & Metabolism published by Oxford University Press and was created by GlobalPort. Oxford University Press takes no responsibility for its accuracy or for the use of any content therein by those reading or downloading such content.
The summary content was prepared by Marie Farrow for Medfyle, reviewed & approved by Raghu G. Mirmira, MD, PhD,
Original article:
Marieke de Vries, Jan Westerink, Karin H A H Kaasjager, Harold W de Valk, Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis, The Journal of Clinical Endocrinology & Metabolism, Volume 105, Issue 12, December 2020, Pages 3842–3853, https://doi.org/10.1210/clinem/dgaa575
The authors of the original article had no part in the creation of the summary.
All Medfyle content, summaries, expert commentaries and slides are owned by GlobalPort (International) Limited. The original journal articles are an exclusive copyright of Endocrine Society/Oxford University Press.
